Project Number 3UH3NS101856-02S1 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Discovery/Development of GABA-A ?5 Positive Allosteric Modulators for Treatment of MCI due to AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $206,281 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official HACHICHA, MOHAMED
